Capital Stock - Common Stock Purchase Agreement - Additional Information (Details) - Novartis [Member] $ / shares in Units, $ in Millions |
Aug. 24, 2017
USD ($)
$ / shares
shares
|
---|---|
Class Of Warrant Or Right [Line Items] | |
Number of common stock agreed to issue and sell | shares | 539,131 |
Common stock sale price | $ / shares | $ 9.2742 |
Aggregate purchase price of common stock agreed to issue and sell | $ 5.0 |
Common stock aggregate fair value | $ 4.8 |
Common stock closing price | $ / shares | $ 8.93 |
Common stock purchase agreement date | Aug. 24, 2017 |
Common stock premium | $ 0.2 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Date the subsidiary or equity investee issued or sold stock, in CCYY-MM-DD format. No definition available.
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Definition Aggregate fair value of common stock. No definition available.
|
X | ||||||||||
- Definition Closing stock price per share. No definition available.
|
X | ||||||||||
- Definition Common stock premium. No definition available.
|
X | ||||||||||
- Details
|